BOLTON SECURITIES CORPORATION’s Medicus Pharma MDCX Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio MDCX Stock Details MDCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46	Buy	+2	New	+$104	﹤0.01%	2010

Other funds holding MDCX

Interchange Capital Partners Pittsburgh, Pennsylvania $598M AUM 31.79% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return

May Hill Capital Cohasset, Massachusetts $510M AUM 23.75% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's MDCX Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Medicus Pharma (MDCX) in Q1 2026: 2 shares worth $46. The stake represents ﹤0.01% of the portfolio and ranks #2010 among its holdings.

22 funds tracked by Wall St. Rank hold MDCX as of Q1 2026.

BOLTON SECURITIES CORPORATION held 2 shares of Medicus Pharma worth $46 as of Q1 2026.
Medicus Pharma was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
Medicus Pharma made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #2010 holding.
22 funds tracked by Wall St. Rank held Medicus Pharma as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.